ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

EDWARD KINKOPF D.O.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,330Medicare Part D Prescriptions Filled, Including Refills

Rank: 387 out of 3001

$607K Total Retail Price of All Prescriptions

Rank: 426 out of 3001

424 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 424 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,608 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 443 375 1 3
LISINOPRIL 401 301 2 2
AMLODIPINE BESYLATE 360 308 3 5
HYDROCODONE-ACETAMINOPHEN 304 170 S3 4 7
SIMVASTATIN 301 204 5 1
OMEPRAZOLE 256 200 6 4
FLUTICASONE PROPIONATE 226 148 7 42
METFORMIN HCL 217 146 8 9
ATORVASTATIN CALCIUM 194 158 9 11
FUROSEMIDE 160 138 10 6
CITALOPRAM HBR 158 119 11 16
TRAMADOL HCL 157 130 12 17
METOPROLOL SUCCINATE 154 128 13 19
CARVEDILOL 148 123 14 25
CRESTOR 142 114 15 33
PRAVASTATIN SODIUM 139 137 16 13
ZOLPIDEM TARTRATE 138 75 17 24
LOVASTATIN 136 118 18 38
AZITHROMYCIN 129 93 19 36
METOPROLOL TARTRATE 128 96 20 8
CLOPIDOGREL 118 114 21 28
TAMSULOSIN HCL 113 106 22 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 103 23 22
WARFARIN SODIUM 99 91 24 12
HYDROCHLOROTHIAZIDE 95 81 25 10
JANUVIA 93 75 26 54
GABAPENTIN 90 44 27 14
SPIRIVA 87 70 28 57
PLAVIX 86 77 29 46
DOXAZOSIN MESYLATE 75 62 30 90
ZETIA 73 65 31 69
ACETAMINOPHEN-CODEINE 71 40 S3 32 141
PROAIR HFA 71 26 32 30
GLYBURIDE 70 37 R 34 62
NEXIUM 70 40 34 23
BUPROPION HCL SR 70 41 34 190
ROPINIROLE HCL 66 44 37 88
GLIPIZIDE 65 39 38 67
KETOCONAZOLE 64 35 39 185
ADVAIR DISKUS 61 12 40 58
LOSARTAN POTASSIUM 61 55 40 21
TRAZODONE HCL 60 32 42 37
AMITRIPTYLINE HCL 59 20 R 43 85
FENOFIBRATE 59 35 43 59
ALPRAZOLAM 58 51 45 98
TIZANIDINE HCL 57 0 46 101
PAROXETINE HCL 57 33 46 60
AMLODIPINE BESYLATE-BENAZEPRIL 57 44 46 78
FLUOXETINE HCL 56 25 49 61
ALENDRONATE SODIUM 56 42 49 26
NAPROXEN 55 37 51 84
OXYCODONE-ACETAMINOPHEN 54 21 S2 52 32
PREDNISONE 53 41 53 39
POTASSIUM CHLORIDE 53 37 53 15
CLONIDINE HCL 52 39 55 64
DIOVAN HCT 50 47 56 109
KLOR-CON M20 50 47 56 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.